12:00 AM
 | 
Mar 02, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Myozyme alglucosidase alfa regulatory update

The EC approved an MAA from Genzyme for Myozyme alglucosidase produced in a 4,000 liter-bioreactor to treat Pompe's disease. Genzyme said the product would be...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >